Fluoride-containing bioactive glasses: Effect of glass design and structure on degradation, pH and apatite formation in simulated body fluid

Acta Biomaterialia

Volumn 6, Issue 8, 2010, Pages 3275-3282

  Brauer, Delia S ^a,b   Karpukhina, Natalia ^a   O'Donnell, Matthew D ^c   Law, Robert V ^a   Hill, Robert G ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c BioCeramic Therapeutics Ltd   (United Kingdom)

Author keywords

Bioactive glass; Bioactivity; Fluorapatite; Fluorine; Solid state NMR

Indexed keywords

APATITE; BIOACTIVE GLASS; BODY FLUIDS; CALCIUM FLUORIDE; FLUORINE; FLUORSPAR; HYDROXYAPATITE; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SILICA; SODIUM COMPOUNDS; X RAY DIFFRACTION;

APATITE FORMATION; CARBONATED HYDROXYAPATITES; CARIES INHIBITIONS; DENTAL APPLICATIONS; FLUORAPATITES; GLASS STRUCTURE; GLASSES DESIGNS; MELT-DERIVED GLASS; SIMULATED BODY FLUIDS; SOLID STATE NMR;

SOLUTIONS;

FLUORAPATITE; FLUORIDE; GLASS; APATITE; ION;

ARTICLE; BODY FLUID; CHEMICAL ANALYSIS; CONTROLLED STUDY; DEGRADATION KINETICS; EQUIPMENT DESIGN; FLUORINE NUCLEAR MAGNETIC RESONANCE; INFRARED SPECTROSCOPY; ION TRANSPORT; PH; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STRUCTURE ANALYSIS; X RAY DIFFRACTION; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POWDER; SOLUBILITY;

APATITES; BODY FLUIDS; FLUORIDES; GLASS; HYDROGEN-ION CONCENTRATION; IONS; MAGNETIC RESONANCE SPECTROSCOPY; POWDERS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 77954085002     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.01.043     Document Type: Article

References (27)

1. Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006;27:2907-15.
2. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res 2000;51:475-83.
3. ®. J Mater Sci Mater Med 2006;17:967-78.
4. Towler MR, Crowley CM, Murphy D, O'Callaghan AMC. A preliminary study of an aluminum-free glass polyalkenoate cement. J Mater Sci Lett 2002;21:1123-6.
5. ®) particulate. J Clin Periodontol 2006;33:86-91.
6. Thuy TT, Nakagaki H, Kato K, Phan AH, Inukai J, Tsuboi S, Nakagaki H, et al. Effect of strontium in combination with fluoride on enamel remineralization in vitro. Arch Oral Biol 2008;53:1017-22.
7. Featherstone JDB. The science and practice of caries prevention. J Am Dental Assoc 2000;131:887-99.
8. Position of the American Dietetic Association: the impact of fluoride on health. J Am Diet Assoc 2005;105:1620-28.
9. Vestergaard P, Jorgensen NR, Schwarz P, Mosekilde L. Effects of treatment with fluoride on bone mineral density and fracture risk - a meta-analysis. Osteoporos Int 2008;19:257-68.
10. Aaseth J, Shimshi M, Gabrilove JL, Birketvedt GS. Fluoride: a toxic or therapeutic agent in the treatment of osteoporosis? J Trace Elem Exp Med 2004;17:83-92.
11. Brauer DS, Karpukhina N, Law RV, Hill RG. Structure of fluoride-containing bioactive glasses. J Mater Chem 2009;19:5629-36.
12. Hill R. An alternative view of the degradation of bioglass. J Mater Sci Lett 1996;15:1122-5.
13. Lusvardi G, Malavasi G, Cortada M, Menabue L, Menziani MC, Pedone A, et al. Elucidation of the structural role of fluorine in potentially bioactive glasses by experimental and computational investigation. J Phys Chem B 2008;112:12730-9.
14. Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res 1990;24:721-34.
15. Toby BH. EXPGUI, a graphical user interface for GSAS. J Appl Crystallogr 2001;34:210-3.
16. Massiot D, Fayon F, Capron M, King I, Le Calve S, Alonso B, Durand JO, et al. Modelling one- and two-dimensional solid-state NMR spectra. Magn Reson Chem 2002;40:70-6.
17. Bohner M, Lemaitre J. Can bioactivity be tested in vitro with SBF solution? Biomaterials 2009;30:2175-9.
18. Lu X, Leng Y. Theoretical analysis of calcium phosphate precipitation in simulated body fluid. Biomaterials 2005;26:1097-108.
19. Kim CY, Clark AE, Hench LL. Early stages of calcium-phosphate layer formation in bioglasses. J Non-Cryst Solids 1989;113:195-202.
20. Jones JR, Sepulveda P, Hench LL. Dose-dependent behavior of bioactive glass dissolution. J Biomed Mater Res 2001;58:720-6.
21. LeGeros RZ, Trautz OR, Klein E, Legeros JP. 2 Types of carbonate substitution in apatite structure. Experientia 1969;25:5-7.
22. Rey C, Combes C, Drouet C, Lebugle A, Sfihi H, Barroug A. Nanocrystalline apatites in biological systems: characterisation, structure and properties. Materialwiss Werkst 2007;38:996-1002.
23. O'Donnell MD, Watts SJ, Hill RG, Law RV. The effect of phosphate content on the bioactivity of soda-lime-phosphosilicate glasses. J Mater Sci Mater Med 2009;20:1611-8.
24. Jäger C, Welzel T, Meyer-Zaika W, Epple M. A solid-state NMR investigation of the structure of nanocrystalline hydroxyapatite. Magn Reson Chem 2006;44:573-80.
25. Fujii E, Kawabata K, Yoshimatsu H, Hayakawa S, Tsuru K, Osaka A. Structure and biomineralization of calcium silicate glasses containing fluoride ions. J Ceram Soc Jpn 2003;111:762-6.
26. Hench LL, Spilman DB, Hench JW, inventors; University of Florida, assignee. Fluoride-modified bioactive glass (Bioglass) and its use as implant material. US patent 4775646; 1988.
27. Lusvardi G, Malavasi G, Menabue L, Aina V, Morterra C. Fluoride-containing bioactive glasses: surface reactivity in simulated body fluids solutions. Acta Biomater 2009;5:3548-62.